Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 2Sarcoma 1Head & Neck 1Endocrine 1CNS 1

Conditions

Head and Neck Neoplasms 2Urogenital Neoplasms 1Thyroid Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Pheochromocytoma 1Paraganglioma 1Neoplastic Syndromes, Hereditary 1Neoplasms, Unknown Primary 1Kidney Neoplasms 1Digestive System Neoplasms 1Central Nervous System Neoplasms 1Breast Neoplasms 1Brain Neoplasms 1Bone Neoplasms 1

Interventions

pembrolizumab 10atezolizumab 4Drug Therapy 4Nivolumab 3Filgrastim 3Cetuximab 3Carboplatin 3cemiplimab 2belinostat 2Peripheral Blood Stem Cell Transplantation 2Patient Reported Outcome Measures 2Fluorouracil 2Counseling 2Bupropion 2Bortezomib 2utomilumab 1tumor necrosis factor-alpha, CNGRC fusion protein, human 1tremelimumab 1tocilizumab 1tanespimycin 1seribantumab 1poly ICLC 1pentetreotide 1pazopanib 1oblimersen 1motexafin gadolinium 1mogamulizumab 1liposomal doxorubicin 1ixabepilone 1gallium Ga 68 dotatate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Kidney Neoplasms × Genetic Testing × Head & Neck × Clear all
NCT03160274 2025-10-15

Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions

The University of Texas Health Science Center at San Antonio

Recruiting
2,000 enrolled
CNSEndocrineGenitourinaryHead & NeckSarcoma

Bone Neoplasms, Kidney Neoplasms, Neoplastic Syndromes, Hereditary, Paraganglioma, Pheochromocytoma, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡